Rush University Medical Center

 

Rush University Medical Center
S

Failure After CAR T-Cell Therapy in Lymphoma: What To Do Next

By Rush University Medical Center FEATURING Scott Smith
By Rush University Medical Center FEATURING Scott Smith
8 views
May 27, 2022
0 Comments
Login to view comments. Click here to Login
2nd Midwest Cellular Conference: Treatment Options for Advanced Hematologic Malignancies
14:43
Rush University Medical Center

Work-Life Balance: Avoiding Burnout

Feat. T. Deshields
13:32
Rush University Medical Center

APPs in Cellular Therapy

Feat. J. Baptista
14:57
Rush University Medical Center

Pharmacy in Cellular Therapy

Feat. A. Seddon
21:51
Rush University Medical Center

Thrombotic Microangiopathies: Modern Diagnosis and Treatments

Feat. S. Cataland
21:33
Rush University Medical Center

HaploSCT: Choosing an Optimal Donor and Novel Strategies to Mitigate…

Feat. J. McGuirk
24:08
Rush University Medical Center

Alternative Allogeneic Transplant Donors: How These Are Changing the…

Feat. P. Stiff
17:24
Rush University Medical Center

Improving Neutropenic Fever Strategies

Feat. J. Green
19:02
Rush University Medical Center

Novel Therapies for Relapsed AML

Feat. S. Abedin
20:10
Rush University Medical Center

Novel Agents for MDS

Feat. S. Dinner
20:21
Rush University Medical Center

Post-HCT Relapse Prevention in Myeloid Malignancies

Feat. M. de Lima
18:11
Rush University Medical Center

Myelofibrosis: Novel Agents and HCT

Feat. S. Verstovsek
18:35
Rush University Medical Center

Upfront Autologous Transplant in Multiple Myeloma

Feat. C. Hofmeister
25:01
Rush University Medical Center

Immunotherapy in MM: Beyond CAR-T

Feat. B. Dhakal
20:02
Rush University Medical Center

Update on CAR-T Therapy for Multiple Myeloma

Feat. N. Callander
20:17
Rush University Medical Center

High-Risk Myeloma: Failures and Future Directions

Feat. S. Usmani
23:53
Rush University Medical Center

R/R Follicular Lymphoma: Novel Agent, Transplant, or CAR T-Cells

Feat. N. Shah
18:18
Rush University Medical Center

Hodgkin Lymphoma: Managing Brentuximab Vedotin/CPI Dual Refractory P…

Feat. V. Kenkre
18:55
Rush University Medical Center

Mantle Cell Lymphoma Management After AutoHCT Relapse

Feat. P. Riedell
21:49
Rush University Medical Center

Failure After CAR T-Cell Therapy in Lymphoma: What To Do Next

Feat. S. Smith
17:34
Rush University Medical Center

CAR T-Cells in Pediatrics

Feat. J. Talano
19:46
Rush University Medical Center

Gene Therapy in Sickle Cell Disease

Feat. S. Jain
14:33
Rush University Medical Center

Cardio-Oncology in Cell Therapy

Feat. T. Okwuosa